+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2024 - 2030- Product Image
Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2024 - 2030- Product Image
New

Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 137 Pages
  • April 2024
  • Region: Global
  • Grand View Research
  • ID: 4661535
Description Jump to:

Metagenomics Market Growth & Trends

The global metagenomics market size is expected to reach USD 4.82 billion by 2030. The market is expected to expand at a CAGR of 13.52% from 2024 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.

A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.

Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.

Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.

Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.

Metagenomics Market Report Highlights

  • The kits & reagents segment held the largest revenue share of over 61.48% in 2023. Kits & reagents are designed for specific applications, such as soil, water, and biological sample analysis.
  • The shotgun sequencing segment accounted for the largest revenue share of 34.08% in 2023. Shotgun sequencing sequences entire genomes by randomly breaking up DNA into small fragments and then sequencing each fragment.
  • The sequencing segment dominated the market with revenue share of 53.39% in 2023. The increase can be attributed to the cost-effectiveness and accuracy achieved through technological advancements in sequencing.
  • In 2023, the environmental segment dominated the market with a revenue share of 25.02%. The role of metagenomics research is swiftly expanding in agriculture and environmental protection, employing sequencing analysis or gene screening to comprehend microorganisms within a specific environment, marking a novel approach to understanding microbial ecosystems.
  • North America dominated the metagenomics market in 2023 with a revenue share of 40.26%. The region's dominance is determined through the presence of key companies, augmented R&D funding, and advancements in sequencing technology.
  • Asia Pacific is expected to grow at the fastest CAGR during the forecast period. This is driven by substantial advancements in metagenomics adoption across diverse applications in India and China.

Table of Contents

Chapter 1. Metagenomics Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Metagenomics Market: Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Metagenomics Market: Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Declining expenses of sequencing
3.3.2. Developments in biotechnology & bioinformatics techniques
3.3.3. Rising interest in microbial screening for different investigations
3.3.4. Emergence of new fields in genomics that complement metagenomics
3.4. Market Restraint Analysis
3.4.1. Limited accessibility to computation and different analytic tools
3.4.2. High overall cost of metagenomics
3.5. Business Environment Analysis
3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.5.2. Porter's Five Forces Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Metagenomics Market: Product Business Analysis
4.1. Segment Dashboard
4.2. Global Metagenomics Market Product Movement Analysis
4.3. Global Metagenomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.3.1. Kits and Reagents
4.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.3.2. Sequencing & Data Analytics Services
4.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.3.3. Software
4.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 5. Metagenomics Market: Technology Business Analysis
5.1. Segment Dashboard
5.2. Global Metagenomics Market Technology Movement Analysis
5.3. Global Metagenomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.3.1. Shotgun Sequencing
5.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.3.2. 16S Sequencing
5.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.3.3. Whole Genome Sequencing
5.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.3.4. Others
5.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 6. Metagenomics Market: Workflow Business Analysis
6.1. Segment Dashboard
6.2. Global Metagenomics Market Workflow Movement Analysis
6.3. Global Metagenomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.3.1. Pre-sequencing
6.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.3.2. Sequencing
6.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.3.3. Data Analysis
6.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 7. Metagenomics Market: Application Business Analysis
7.1. Segment Dashboard
7.2. Global Metagenomics Market Application Movement Analysis
7.3. Global Metagenomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.3.1. Environmental
7.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.3.2. Clinical Diagnostics
7.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.3.3. Drug Discovery
7.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.3.4. Biotechnology
7.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.3.5. Food & nutrition
7.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.3.6. Others
7.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. North America
8.3.1. North America Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.4. Europe
8.4.1. Europe Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.4.4. Spain
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.4.5. France
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.4.6. Italy
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. JAPAN
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.5.7. Australia
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6. Latin America
8.6.1. Latin America Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.3. Mexico
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Mexico Metagenomics Market, 2018 - 2030 (USD Million)
8.6.4. Argentina
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7. MEA
8.7.1. MEA Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.4. UAE
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Participant's Overview
9.4.1. Bio-Rad Laboratories, Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Illumina, Inc.
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. PerkinElmer, Inc
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Thermo Fisher Scientific, Inc
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Novogene Co., Ltd.
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Promega Corporation
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. QIAGEN
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Takara Bio, Inc.
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Oxford Nanopore Technologies plc.
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. F. Hoffmann-La Roche Ltd.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 4 Global Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 5 Global Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 6 Global Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 7 Global Sexual Health Supplements Market, By Region, 2018 - 2030 (USD Million)
Table 8 North America Metagenomics Market, Region, 2018 - 2030 (USD Million)
Table 9 North America Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 10 North America Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 11 North America Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 12 North America Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 13 U.S. Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 14 U.S. Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 15 U.S. Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 16 U.S. Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 17 Canada Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 18 Canada Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 19 Canada Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 20 Canada Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 21 Europe Metagenomics Market, Region, 2018 - 2030 (USD Million)
Table 22 Europe Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 23 Europe Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 24 Europe Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 25 Europe Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 26 UK Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 27 UK Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 28 UK Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 29 UK Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 30 Germany Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 31 Germany Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 32 Germany Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 33 Germany Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 34 France Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 35 France Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 36 France Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 37 France Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 38 Italy Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 39 Italy Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 40 Italy Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 41 Italy Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 42 Spain Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 43 Spain Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 44 Spain Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 45 Spain Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 46 Sweden Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 47 Sweden Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 48 Sweden Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 49 Sweden Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 50 Norway Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 51 Norway Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 52 Norway Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 53 Norway Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 54 Denmark Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 55 Denmark Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 56 Denmark Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 57 Denmark Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Metagenomics Market, Region, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 63 Japan Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 64 Japan Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 65 Japan Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 66 Japan Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 67 China Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 68 China Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 69 China Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 70 China Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 71 India Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 72 India Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 73 India Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 74 India Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 75 Australia Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 76 Australia Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 77 Australia Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 78 Australia Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 79 South Korea Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 80 South Korea Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 81 South Korea Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 82 South Korea Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 83 Thailand Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 84 Thailand Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 85 Thailand Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 86 Thailand Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 87 Latin America Metagenomics Market, Region, 2018 - 2030 (USD Million)
Table 88 Latin America Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 89 Latin America Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 90 Latin America Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 91 Latin America Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 92 Brazil Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 93 Brazil Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 94 Brazil Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 95 Brazil Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 96 Mexico Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 97 Mexico Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 98 Mexico Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 99 Mexico Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 100 Argentina Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 101 Argentina Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 102 Argentina Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 103 Argentina Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 104 MEA Metagenomics Market, Region, 2018 - 2030 (USD Million)
Table 105 MEA Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 106 MEA Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 107 MEA Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 108 MEA Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 109 South Africa Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 110 South Africa Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 111 South Africa Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 112 South Africa Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 117 UAE Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 118 UAE Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 119 UAE Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 120 UAE Metagenomics Market, By Application, 2018 - 2030 (USD Million)
Table 121 Kuwait Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 122 Kuwait Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 123 Kuwait Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 124 Kuwait Metagenomics Market, By Application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Metagenomics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 Sexual health supplements market driver analysis
Fig. 14 Metagenomics market restraint analysis
Fig. 15 Metagenomics market: Porter's analysis
Fig. 16 Metagenomics market: PESTEL analysis
Fig. 17 Metagenomics market: Technology outlook and key takeaways
Fig. 18 Metagenomics market: Technology market share analysis, 2023 - 2030
Fig. 19 Global metagenomics by shotgun sequencing market, 2018 - 2030 (USD Million)
Fig. 20 Global metagenomics by 16S sequencing market, 2018 - 2030 (USD Million)
Fig. 21 Global metagenomics by whole genome sequencing market, 2018 - 2030 (USD Million)
Fig. 22 Global metagenomics by others market, 2018 - 2030 (USD Million)
Fig. 23 Metagenomics market: Product outlook and key takeaways
Fig. 24 Metagenomics market: Product market share analysis, 2023 - 2030
Fig. 25 Global metagenomics by kits & reagents market, 2018 - 2030 (USD Million)
Fig. 26 Global metagenomics by sequencing & data analytics services market, 2018 - 2030 (USD Million)
Fig. 27 Global metagenomics by software market, 2018 - 2030 (USD Million)
Fig. 28 Metagenomics market: Application outlook and key takeaways
Fig. 29 Metagenomics market: Application market share analysis, 2023 - 2030
Fig. 30 Global metagenomics by environmental market, 2018 - 2030 (USD Million)
Fig. 31 Global metagenomics by clinical diagnostics market, 2018 - 2030 (USD Million)
Fig. 32 Global metagenomics by drug discovery market, 2018 - 2030 (USD Million)
Fig. 33 Global metagenomics by biotechnology market, 2018 - 2030 (USD Million)
Fig. 34 Global metagenomics by food & nutrition market, 2018 - 2030 (USD Million)
Fig. 35 Global metagenomics by others market, 2018 - 2030 (USD Million)
Fig. 36 Metagenomics market: Workflow outlook and key takeaways
Fig. 37 Metagenomics market: Workflow market share analysis, 2023 - 2030
Fig. 38 Global metagenomics by pre-sequencing market, 2018 - 2030 (USD Million)
Fig. 39 Global metagenomics by sequencing market, 2018 - 2030 (USD Million)
Fig. 40 Global metagenomics by data analysis market, 2018 - 2030 (USD Million)
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 U.S. key country dynamics
Fig. 44 U.S. metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Canada key country dynamics
Fig. 46 Canada metagenomics market, 2018 - 2030 (USD Million)
Fig. 47 Europe metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 UK key country dynamics
Fig. 49 UK metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Germany key country dynamics
Fig. 51 Germany metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 France key country dynamics
Fig. 53 France metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Italy key country dynamics
Fig. 55 Italy metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Spain key country dynamics
Fig. 57 Spain metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Denmark key country dynamics
Fig. 59 Denmark metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Sweden key country dynamics
Fig. 61 Sweden metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Norway key country dynamics
Fig. 63 Norway metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Asia-Pacific metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Japan key country dynamics
Fig. 66 Japan metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 China key country dynamics
Fig. 68 China metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 India key country dynamics
Fig. 70 India metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Australia key country dynamics
Fig. 72 Australia metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Thailand key country dynamics
Fig. 74 Thailand metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 South Korea key country dynamics
Fig. 76 South Korea metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Latin America metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Brazil key country dynamics
Fig. 79 Brazil metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Mexico key country dynamics
Fig. 81 Mexico metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Argentina key country dynamics
Fig. 83 Argentina metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 MEA metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 South Africa key country dynamics
Fig. 86 South Africa metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Saudi Arabia key country dynamics
Fig. 88 Saudi Arabia metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 UAE key country dynamics
Fig. 90 UAE metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Kuwait key country dynamics
Fig. 92 Kuwait metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 93 Key company categorization
Fig. 94 Company market positioning
Fig. 95 Market participant categorization
Fig. 96 Strategy framework

Companies Mentioned

  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc
  • Thermo Fisher Scientific, Inc
  • Novogene Co., Ltd.
  • Promega Corporation
  • QIAGEN
  • Takara Bio, Inc.
  • Oxford Nanopore Technologies plc.
  • F. Hoffmann-La Roche Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages137
PublishedApril 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.82 Billion
Compound Annual Growth Rate13.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Metagenomic Sequencing Market by Product & Service (Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables), Workflow (Data Processing & Analysis, Sample Processing & Library Preparation, Sequencing), Technology, Application - Forecast 2024-2030 - Product Image

Global Metagenomic Sequencing Market by Product & Service (Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables), Workflow (Data Processing & Analysis, Sample Processing & Library Preparation, Sequencing), Technology, Application - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial), and Region - Forecast to 2028 - Product Image

Global Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial), and Region - Forecast to 2028

  • Report
  • 257 Pages
  • Global
From
Global Metagenomics Sequencing Market Analysis & Forecast to 2024-2034 - Product Image

Global Metagenomics Sequencing Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Metagenomics Global Market Report 2024 - Product Image

Metagenomics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Metagenomics Market - Forecasts from 2023 to 2028 - Product Image

Metagenomics Market - Forecasts from 2023 to 2028

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.